[ascct] NC3Rs/MHRA survey on human tissue for safety pharmacology

  • From: Kristie Sullivan <KSullivan@xxxxxxxx>
  • To: "ascct@xxxxxxxxxxxxx" <ascct@xxxxxxxxxxxxx>
  • Date: Mon, 19 Aug 2013 16:46:58 -0400

The UK National Centre for the Replacement, Refinement and Reduction of Animals 
in Research (NC3Rs; www.nc3rs.org.uk<http://www.nc3rs.org.uk/>) and the 
Medicines and Healthcare products Regulatory Authority (MHRA; 
http://www.mhra.gov.uk/) have convened an expert working group to generate an 
evidence base which will inform the use of human tissue in testing the safety 
of potential new medicines, with an initial focus on safety pharmacology 
studies.

The attached survey is being distributed widely to the safety assessment 
community to better understand the extent of human tissue use for assessing 
safety pharmacology and what the barriers might be to wider adoption of these 
approaches to generate data to support clinical trial applications.

Please can you complete the survey and help provide the evidence base to move 
these aspirations forward.

The deadline for responding to this consultation is 27 September 2013.

If you would like to discuss this further, please contact Anthony Holmes 
(anthony.holmes@xxxxxxxxxxxx<mailto:anthony.holmes@xxxxxxxxxxxx>) who is 
leading this initiative.

Kristie Sullivan
Secretary, ASCCT
www.ascctox.org<http://www.ascctox.org>

Attachment: NC3Rs-MHRA Human tissue for safety pharmacology consultation.xls
Description: NC3Rs-MHRA Human tissue for safety pharmacology consultation.xls

Other related posts:

  • » [ascct] NC3Rs/MHRA survey on human tissue for safety pharmacology - Kristie Sullivan